Literature DB >> 20446765

Copper and myeloperoxidase-modified LDLs activate Nrf2 through different pathways of ROS production in macrophages.

Damien Calay1, Alexandre Rousseau, Laurine Mattart, Vincent Nuyens, Cédric Delporte, Pierre Van Antwerpen, Nicole Moguilevsky, Thierry Arnould, Karim Zouaoui Boudjeltia, Martine Raes.   

Abstract

Low-density lipoprotein (LDL) oxidation is a key step in atherogenesis, promoting the formation of lipid-laden macrophages. Here, we compared the effects of copper-oxidized LDLs (OxLDLs) and of the more physiologically relevant myeloperoxidase-oxidized LDLs (MoxLDLs) in murine RAW264.7 macrophages and in human peripheral blood monocyte-derived macrophages. Both oxidized LDLs, contrary to native LDLs, induced foam cell formation and an intracellular accumulation of reactive oxygen species (ROS). This oxidative stress was responsible for the activation of the NF-E2-related factor 2 (Nrf2) transcription factor, and the subsequent Nrf2-dependent overexpression of the antioxidant genes, Gclm and HO-1, as evidenced by the invalidation of Nrf2 by RNAi. MoxLDLs always induced a stronger response than OxLDLs. These differences could be partly explained by specific ROS-producing mechanisms differing between OxLDLs and MoxLDLs. Whereas both types of oxidized LDLs caused ROS production partly by NADPH oxidase, only MoxLDLs-induced ROS production was dependent on cytosolic PLA2. This study highlights that OxLDLs and MoxLDLs induce an oxidative stress, through distinct ROS-producing mechanisms, which is responsible for the differential activation of the Nrf2 pathway. These data clearly suggest that results obtained until now with copper oxidized-LDLs should be carefully reevaluated, taking into consideration physiologically more relevant oxidized LDLs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446765     DOI: 10.1089/ars.2009.2971

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  14 in total

1.  Celecoxib induces heme oxygenase-1 expression in macrophages and vascular smooth muscle cells via ROS-dependent signaling pathway.

Authors:  Jang-Shiun Wang; Feng-Ming Ho; Hao-Cheng Kang; Wan-Wan Lin; Kuo-Chin Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-22       Impact factor: 3.000

Review 2.  Unexpected Role of MPO-Oxidized LDLs in Atherosclerosis: In between Inflammation and Its Resolution.

Authors:  Cecilia Tangeten; Karim Zouaoui Boudjeltia; Cedric Delporte; Pierre Van Antwerpen; Keziah Korpak
Journal:  Antioxidants (Basel)       Date:  2022-04-28

3.  Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo.

Authors:  Alison C Brewer; Thomas V A Murray; Matthew Arno; Min Zhang; Narayana P Anilkumar; Giovanni E Mann; Ajay M Shah
Journal:  Free Radic Biol Med       Date:  2011-04-22       Impact factor: 7.376

4.  Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men.

Authors:  Karim Zouaoui Boudjeltia; Brice Faraut; Maria José Esposito; Patricia Stenuit; Michal Dyzma; Pierre Van Antwerpen; Dany Brohée; Luc Vanhamme; Nicole Moguilevsky; Michel Vanhaeverbeek; Myriam Kerkhofs
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

5.  Myeloperoxidase oxidized LDL interferes with endothelial cell motility through miR-22 and heme oxygenase 1 induction: possible involvement in reendothelialization of vascular injuries.

Authors:  Jalil Daher; Maud Martin; Alexandre Rousseau; Vincent Nuyens; Hussein Fayyad-Kazan; Pierre Van Antwerpen; Guy Courbebaisse; Philippe Martiat; Bassam Badran; Frank Dequiedt; Karim Zouaoui Boudjeltia; Luc Vanhamme
Journal:  Mediators Inflamm       Date:  2014-11-02       Impact factor: 4.711

6.  Effects of copper sulfate-oxidized or myeloperoxidase-modified LDL on lipid loading and programmed cell death in macrophages under hypoxia.

Authors:  Benoit Vlaminck; Damien Calay; Marie Genin; Aude Sauvage; Noelle Ninane; Karim Zouaoui Boudjeltia; Martine Raes; Carine Michiels
Journal:  Hypoxia (Auckl)       Date:  2014-09-23

7.  Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

Authors:  Cédric Delporte; Karim Zouaoui Boudjeltia; Caroline Noyon; Paul G Furtmüller; Vincent Nuyens; Marie-Christine Slomianny; Philippe Madhoun; Jean-Marc Desmet; Pierre Raynal; Damien Dufour; Chintan N Koyani; Florence Reyé; Alexandre Rousseau; Michel Vanhaeverbeek; Jean Ducobu; Jean-Claude Michalski; Jean Nève; Luc Vanhamme; Christian Obinger; Ernst Malle; Pierre Van Antwerpen
Journal:  J Lipid Res       Date:  2014-02-17       Impact factor: 5.922

Review 8.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

Review 9.  Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis.

Authors:  Ilaria Peluso; Arturo Cavaliere; Maura Palmery
Journal:  J Biomed Sci       Date:  2016-07-04       Impact factor: 8.410

10.  Vascular Protective Role of Samul-Tang in HUVECs: Involvement of Nrf2/HO-1 and NO.

Authors:  Eun Sik Choi; Yun Jung Lee; Chang Seob Seo; Jung Joo Yoon; Byung Hyuk Han; Min Cheol Park; Dae Gill Kang; Ho Sub Lee
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.